Basic Information

Symbol
circGCN1L1
RNA Class
circRNA
Alias
GCN1 Activator Of EIF2AK4 KIAA0219 GCN1L1 GCN1L GCN1 (General Control Of Amino-Acid Synthesis 1, Yeast)-Like 1 General Control Of Amino-Acid Synthesis 1-Like Protein 1 GCN1, EIF2 Alpha Kinase Activator Homolog GCN1 EIF-2-Alpha Kinase Activator Homolog Stalled Ribosome Sensor GCN1 Translational Activator GCN1 GCN1-Like Protein 1 HsGCN1 Peroxisome Proliferator Activated Receptor Interacting Complex Protein GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 (Yeast) GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 EIF-2-Alpha Kinase Activator GCN1 PRIC295
Location (GRCh37)
12:120567080-120632513 UCSC Genome Browser
Location (GRCh38)
Host gene
GCN1L1
Host category
mRNA
Forensic tag(s)
Other applications
External database

Transcripts

ID Type Location (GRCh37) Location (GRCh38) Length GC content
hsa_GCN1L1_0019600 Exon-Exon chr12:120612965-120621480 chr12:120175162-120183677 776 nt 0.5412
hsa_GCN1L1_0019700 Exon-Exon chr12:120612965-120628203 chr12:120175162-120190400 1075 nt 0.5367
hsa_GCN1L1_0019800 Exon-Exon chr12:120612965-120632513 chr12:120175162-120194710 1106 nt 0.5434
hsa_GCN1L1_0020000 Exon-Exon chr12:120613549-120628203 chr12:120175746-120190400 1024 nt 0.5381
hsa_GCN1L1_0020200 Exon-Exon chr12:120615250-120616753 chr12:120177447-120178950 412 nt 0.5316
hsa_GCN1L1_0020300 Exon-Exon chr12:120615487-120616753 chr12:120177684-120178950 303 nt 0.5545
hsa_GCN1L1_0020400 Exon-Exon chr12:120615487-120622690 chr12:120177684-120184887 608 nt 0.5559
hsa_GCN1L1_0020500 Exon-Exon chr12:120615487-120628203 chr12:120177684-120190400 711 nt 0.5443
hsa_GCN1L1_0020600 Exon-Exon chr12:120615487-120632513 chr12:120177684-120194710 742 nt 0.5539
hsa_GCN1L1_0020900 Exon-Exon chr12:120621372-120622690 chr12:120183569-120184887 305 nt 0.5574
Showing 141 to 150 of 152 entries
Forensic Context

A review consolidating existing research indicates that in various mammalian species, the circGCN1L1 serves as an example where its expression was experimentally abolished using CRISPR/Cas9 genome-editing without affecting the expression of its corresponding linear mRNA [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].